Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Bente Glintborg; Daniela Di Giuseppe; Johan K. Wallman; Sella A. Provan; Dan Nordstrom; Anna-Mari Hokkanen; Jenny Österlund; Eirik Kristianslund; Tore K. Kvien; Bjorn Gudbjornsson; Merete Lund Hetland; Brigitte Michelsen; Lennart Jacobsson; Johan Askling; Ulf Lindström

doi:10.1093/rheumatology/keac358

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Bente Glintborg, Daniela Di Giuseppe, Johan K. Wallman, Sella A. Provan, Dan Nordstrom, Anna-Mari Hokkanen, Jenny Österlund, Eirik Kristianslund, Tore K. Kvien, Bjorn Gudbjornsson, Merete Lund Hetland, Brigitte Michelsen, Lennart Jacobsson, Johan Askling, Ulf Lindström

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	Rheumatology
Vuosikerta	62
Numero	2
Sivut	647–658
Sivumäärä	12
ISSN	1462-0324
DOI - pysyväislinkit	https://doi.org/10.1093/rheumatology/keac358
Tila	Julkaistu - 1 helmik. 2023
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3121 Yleislääketiede, sisätaudit ja muut kliiniset lääketieteet

Pääsy asiakirjaan

10.1093/rheumatology/keac358

keac358Lopullinen julkaistu versio, 815 KBLisenssi: CC BY-NC

Siteeraa tätä

Glintborg, B., Di Giuseppe, D., Wallman, J. K., Provan, S. A., Nordstrom, D., Hokkanen, A-M., Österlund, J., Kristianslund, E., Kvien, T. K., Gudbjornsson, B., Hetland, M. L., Michelsen, B., Jacobsson, L., Askling, J., & Lindström, U. (2023). Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries. Rheumatology, 62(2), 647–658. https://doi.org/10.1093/rheumatology/keac358

@article{2d0ed22d2e7941209af6c8338cde76bd,

title = "Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries",

keywords = "3121 General medicine, internal medicine and other clinical medicine, DMARDs, Biologic therapies, Epidemiology, Immunosuppressants, Spondylarthropathies",

author = "Bente Glintborg and {Di Giuseppe}, Daniela and Wallman, {Johan K.} and Provan, {Sella A.} and Dan Nordstrom and Anna-Mari Hokkanen and Jenny {\"O}sterlund and Eirik Kristianslund and Kvien, {Tore K.} and Bjorn Gudbjornsson and Hetland, {Merete Lund} and Brigitte Michelsen and Lennart Jacobsson and Johan Askling and Ulf Lindstr{\"o}m",

year = "2023",

month = feb,

day = "1",

doi = "10.1093/rheumatology/keac358",

language = "English",

volume = "62",

pages = "647–658",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "2",

}

Glintborg, B, Di Giuseppe, D, Wallman, JK, Provan, SA, Nordstrom, D, Hokkanen, A-M, Österlund, J, Kristianslund, E, Kvien, TK, Gudbjornsson, B, Hetland, ML, Michelsen, B, Jacobsson, L, Askling, J & Lindström, U 2023, 'Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries', Rheumatology, Vuosikerta 62, Nro 2, Sivut 647–658. https://doi.org/10.1093/rheumatology/keac358

TY - JOUR

T1 - Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

AU - Glintborg, Bente

AU - Di Giuseppe, Daniela

AU - Wallman, Johan K.

AU - Provan, Sella A.

AU - Nordstrom, Dan

AU - Hokkanen, Anna-Mari

AU - Österlund, Jenny

AU - Kristianslund, Eirik

AU - Kvien, Tore K.

AU - Gudbjornsson, Bjorn

AU - Hetland, Merete Lund

AU - Michelsen, Brigitte

AU - Jacobsson, Lennart

AU - Askling, Johan

AU - Lindström, Ulf

PY - 2023/2/1

Y1 - 2023/2/1

KW - 3121 General medicine, internal medicine and other clinical medicine

KW - DMARDs

KW - Biologic therapies

KW - Epidemiology

KW - Immunosuppressants

KW - Spondylarthropathies

U2 - 10.1093/rheumatology/keac358

DO - 10.1093/rheumatology/keac358

M3 - Article

VL - 62

SP - 647

EP - 658

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 2

ER -